Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100308199> ?p ?o ?g. }
- W3100308199 endingPage "151" @default.
- W3100308199 startingPage "151" @default.
- W3100308199 abstract "Growing evidence suggests that prescription opioid use affects depression and anxiety disorders; however, observational studies are subject to confounding, making causal inference and determining the direction of these associations difficult.To investigate the potential bidirectional associations between the genetic liability for prescription opioid and other nonopioid pain medications and both major depressive disorder (MDD) and anxiety and stress-related disorders (ASRD) using genetically based methods.We performed 2-sample mendelian randomization (MR) using summary statistics from genome-wide association studies (GWAS) to assess potential associations of self-reported prescription opioid and nonopioid analgesics, including nonsteroidal anti-inflammatories (NSAIDs) and acetaminophen-like derivatives use with MDD and ASRD. The GWAS data were derived from participants of predominantly European ancestry included in observational cohorts. Data were analyzed February 20, 2020, to May 4, 2020.Major depressive disorder, ASRD, and self-reported pain medications (opioids, NSAIDs, anilides, and salicylic acid).The GWAS data were derived from participants of predominantly European ancestry included in the population-based UK Biobank and Lundbeck Foundation Initiative for Integrative Psychiatric Research studies: approximately 54% of the initial UK Biobank sample and 55.6% of the Lundbeck Foundation Initiative for Integrative Psychiatric Research sample selected for the ASRD GWAS were women. In a combined sample size of 737 473 study participants, single-variable MR showed that genetic liability for increased prescription opioid use was associated with increased risk of both MDD (odds ratio [OR] per unit increase in log odds opioid use, 1.14; 95% CI, 1.06-1.22; P < .001) and ASRD (OR, 1.24; 95% CI, 1.07-1.44; P = .004). Using multivariable MR, these opioid use estimates remained after accounting for other nonopioid pain medications (MDD OR, 1.14; 95% CI, 1.04-1.25; P = .005; ASRD OR, 1.30; 95% CI, 1.08-1.46; P = .006), and in separate models, accounting for comorbid pain conditions. Bidirectional analyses showed that genetic liability for MDD but not ASRD was associated with increased prescription opioid use risk (OR, 1.18; 95% CI, 1.08-1.30; P < .001). These estimates were generally consistent across single-variable and multivariable inverse variance-weighted (MV-IVW) and MR-Egger sensitivity analyses. Pleiotropy-robust methods did not indicate bias in any MV-IVW estimates.The findings of this mendelian randomization analysis suggest evidence for potential causal associations between the genetic liability for increased prescription opioid use and the risk for MDD and ASRD. While replication studies are necessary, these findings may inform prevention and intervention strategies directed toward the opioid epidemic and depression." @default.
- W3100308199 created "2020-11-23" @default.
- W3100308199 creator A5013184354 @default.
- W3100308199 creator A5075112055 @default.
- W3100308199 creator A5089957785 @default.
- W3100308199 date "2021-02-01" @default.
- W3100308199 modified "2023-10-16" @default.
- W3100308199 title "Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders" @default.
- W3100308199 cites W1529509939 @default.
- W3100308199 cites W1910131335 @default.
- W3100308199 cites W1964472634 @default.
- W3100308199 cites W1972242861 @default.
- W3100308199 cites W1974086725 @default.
- W3100308199 cites W1976915332 @default.
- W3100308199 cites W1982223091 @default.
- W3100308199 cites W1988363612 @default.
- W3100308199 cites W1997092727 @default.
- W3100308199 cites W2008836462 @default.
- W3100308199 cites W2015721095 @default.
- W3100308199 cites W2031403388 @default.
- W3100308199 cites W2032643119 @default.
- W3100308199 cites W2034952894 @default.
- W3100308199 cites W2038709220 @default.
- W3100308199 cites W2071801806 @default.
- W3100308199 cites W2072301923 @default.
- W3100308199 cites W2079852966 @default.
- W3100308199 cites W2097572674 @default.
- W3100308199 cites W2100360240 @default.
- W3100308199 cites W2103783427 @default.
- W3100308199 cites W2106036991 @default.
- W3100308199 cites W2113699335 @default.
- W3100308199 cites W2126948325 @default.
- W3100308199 cites W2130036162 @default.
- W3100308199 cites W2133978074 @default.
- W3100308199 cites W2153998371 @default.
- W3100308199 cites W2467892406 @default.
- W3100308199 cites W2490528887 @default.
- W3100308199 cites W2552320768 @default.
- W3100308199 cites W2568896786 @default.
- W3100308199 cites W2614566443 @default.
- W3100308199 cites W2723723801 @default.
- W3100308199 cites W2738082385 @default.
- W3100308199 cites W2739081735 @default.
- W3100308199 cites W2762591582 @default.
- W3100308199 cites W2803072880 @default.
- W3100308199 cites W2805983714 @default.
- W3100308199 cites W2810498355 @default.
- W3100308199 cites W2810852503 @default.
- W3100308199 cites W2889166554 @default.
- W3100308199 cites W2902748282 @default.
- W3100308199 cites W2913696992 @default.
- W3100308199 cites W2921028723 @default.
- W3100308199 cites W2924950986 @default.
- W3100308199 cites W2942053120 @default.
- W3100308199 cites W2946025936 @default.
- W3100308199 cites W2946441043 @default.
- W3100308199 cites W2947436212 @default.
- W3100308199 cites W2949275660 @default.
- W3100308199 cites W2952110053 @default.
- W3100308199 cites W2953121869 @default.
- W3100308199 cites W2973624187 @default.
- W3100308199 cites W3012912937 @default.
- W3100308199 cites W3031982843 @default.
- W3100308199 cites W4210703904 @default.
- W3100308199 cites W4229620957 @default.
- W3100308199 cites W4239508938 @default.
- W3100308199 cites W4241011144 @default.
- W3100308199 cites W4243796923 @default.
- W3100308199 cites W4255721391 @default.
- W3100308199 cites W4255888770 @default.
- W3100308199 doi "https://doi.org/10.1001/jamapsychiatry.2020.3554" @default.
- W3100308199 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7658804" @default.
- W3100308199 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33175090" @default.
- W3100308199 hasPublicationYear "2021" @default.
- W3100308199 type Work @default.
- W3100308199 sameAs 3100308199 @default.
- W3100308199 citedByCount "67" @default.
- W3100308199 countsByYear W31003081992020 @default.
- W3100308199 countsByYear W31003081992021 @default.
- W3100308199 countsByYear W31003081992022 @default.
- W3100308199 countsByYear W31003081992023 @default.
- W3100308199 crossrefType "journal-article" @default.
- W3100308199 hasAuthorship W3100308199A5013184354 @default.
- W3100308199 hasAuthorship W3100308199A5075112055 @default.
- W3100308199 hasAuthorship W3100308199A5089957785 @default.
- W3100308199 hasBestOaLocation W31003081991 @default.
- W3100308199 hasConcept C104317684 @default.
- W3100308199 hasConcept C106208931 @default.
- W3100308199 hasConcept C118552586 @default.
- W3100308199 hasConcept C126322002 @default.
- W3100308199 hasConcept C135763542 @default.
- W3100308199 hasConcept C153209595 @default.
- W3100308199 hasConcept C156957248 @default.
- W3100308199 hasConcept C185592680 @default.
- W3100308199 hasConcept C23131810 @default.
- W3100308199 hasConcept C2779901538 @default.
- W3100308199 hasConcept C2780051608 @default.
- W3100308199 hasConcept C2780733359 @default.